Related Experiment Videos
Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks
Annals of Neurology
|February 1, 1995
Summary
The apolipoprotein E epsilon 4 (apo E ε4) allele significantly increases Alzheimer's disease risk across ethnicities. However, the apo E ε2/ε3 genotype shows varied associations with Alzheimer's risk among different racial groups.
Area of Science:
- Neuroscience
- Genetics
- Epidemiology
Background:
- The apolipoprotein E epsilon 4 (apo E ε4) allele is a significant risk factor for Alzheimer's disease (AD).
- The precise mechanism, whether biological effects of apo E ε4 or linkage disequilibrium with other genes, remains critical to elucidate.
- Understanding ethnic variations in apo E allele associations with AD is crucial for targeted prevention and treatment strategies.
Purpose of the Study:
- To investigate the association between apolipoprotein E (apo E) gene polymorphisms and Alzheimer's disease risk in a multiethnic community.
- To examine how different apo E genotypes (ε4/ε4, ε4 heterozygosity, ε2/ε3) influence AD risk across White, African-American, and Hispanic populations.
- To explore potential ethnic and age-related differences in the impact of apo E polymorphisms on Alzheimer's disease.
Main Methods:
- A community-based study conducted in northern Manhattan.
- Genotyping for apolipoprotein E (apo E) polymorphisms (ε2, ε3, ε4) in participants.
- Statistical analysis to compare allele frequencies and assess the risk of Alzheimer's disease associated with different apo E genotypes across ethnic groups (White, African-American, Hispanic).
Main Results:
- A fivefold increased risk of Alzheimer's disease was observed in individuals homozygous for apo E ε4 across all ethnic groups.
- A twofold increased risk of Alzheimer's disease was associated with apo E ε4 heterozygosity, with a weaker association in African-Americans compared to Hispanics and Whites.
- The apo E ε2/ε3 genotype showed an eightfold increased risk in African-Americans but a reduced risk in Whites. Allelic frequencies of apo E ε4 were higher in patients than controls up to age 70, while apo E ε2 was higher in patients after age 70 for African-Americans and Hispanics.
Conclusions:
- Apolipoprotein E ε4 is a significant, albeit variable, risk factor for Alzheimer's disease across diverse ethnic groups.
- Ethnic-specific effects of apo E polymorphisms, particularly the ε2 allele, influence Alzheimer's disease risk, suggesting complex genetic and environmental interactions.
- Age modifies the association between apo E allele frequencies and Alzheimer's disease risk, highlighting the need for age- and ethnicity-stratified analyses.